Gemma Nicole Jones

Title: The Innovative Contributions of Gemma Nicole Jones

Introduction

Gemma Nicole Jones is a notable inventor based in Little Chesterford, GB. She has made significant contributions to the field of oncology through her innovative research and patented methods. Her work focuses on improving cancer treatment outcomes by understanding the sensitivity of tumor cells to anti-cancer therapies.

Latest Patents

Gemma holds a patent for her invention titled "Methods based on the detection of RAD51 foci in tumor cells." This invention provides a method that allows for the determination of whether a subject diagnosed with cancer is sensitive or resistant to anti-cancer treatment. The method is based on the level of cells with RAD51 foci in a sample containing tumor cells isolated from the subject. Notably, the subject must not have received chemotherapy within 24 hours prior to sample isolation, and the sample should not be treated with any method that induces DNA damage before determining the level of cells with RAD51 foci. This innovative approach has the potential to enhance personalized cancer treatment strategies.

Career Highlights

Throughout her career, Gemma has worked with prominent organizations, including the Fundació Privada Institut D'Investigació Oncològica de Vall Hebron and AstraZeneca UK Limited. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Gemma has collaborated with esteemed colleagues such as Violeta Serra Elizalde and Judith Balmaña Gelpi. These partnerships have further enriched her research and have played a crucial role in advancing her innovative work in oncology.

Conclusion

Gemma Nicole Jones is a pioneering inventor whose work in cancer research has the potential to transform treatment approaches. Her patented methods and collaborations with leading organizations highlight her commitment to improving patient outcomes in oncology.